Latest News and Press Releases
Want to stay updated on the latest news?
-
The Presentation Will Occur at 5:30pm Eastern / 2:30pm Pacific Time SAN DIEGO, June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical...
-
The Event Occurs Friday, May 21st at 11am Eastern / 8am Pacific Time SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical...
-
Sigyn Therapy™ demonstrates the ability to address viral pathogens, including SARS-CoV-2 (COVID-19) SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc....
-
The Interactive Videoconference Occurs Today at 4pm Eastern / 1pm Pacific Time SAN DIEGO, April 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a...
-
The Event Occurs Tomorrow, March 17th at 12pm Eastern / 9am Pacific Time SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical...
-
SAN DIEGO, March 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory...
-
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory...
-
Mr. Lynam to Oversee Clinical Studies of Sigyn Therapy™ to Treat Life-Threatening Inflammatory Conditions SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc....
-
SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), disclosed today that its Chairman and CEO Jim Joyce is featured in an interview with The...
-
SAN DIEGO, Jan. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. Dear...